Fri, Aug 22, 2014, 4:10 PM EDT - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

Celsion Corp. Message Board

  • johnnyboy5354 johnnyboy5354 Feb 1, 2013 5:58 PM Flag

    Can't stand the HEAT

    Celsion (NASDAQ: CLSN ) wins the dubious honor of worst health-care stock over the last five days. Shares collapsed more than 80% after the company announced that ThermoDox, an encapsulated form of cancer drug doxorubicin activated by heat generated by radiofrequency ablation, failed to meet objectives in a phase 3 trial referred to as the HEAT study.

    Unfortunately, the situation is even worse than it sounds. Celsion CEO Michael Tardugno stated in a conference call following the announcement that the results "were not even close." Not only did ThermoDox not meet the primary study endpoint, it didn't even perform as well as the control arm in improving progression-free survival rates for liver cancer patients.

 
CLSN
3.16+0.02(+0.64%)4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.